The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SARC016: Phase II study of everolimus in combination with bevacizumab in sporadic and neurofibromatosis type 1 (NF1) related refractory malignant peripheral nerve sheath tumors (MPNST).
 
Brigitte C. Widemann
No Relationships to Disclose
 
Christian Frederick Meyer
Travel, Accommodations, Expenses - Plexxikon
 
Gregory Michael Cote
Consulting or Advisory Role - Advance Medical Designs
Research Funding - Agios (Inst); Boston Biomedical (Inst); Epizyme (Inst); Macrogenics (Inst); PharmaMar (Inst)
 
Rashmi Chugh
Research Funding - Biomarin; Lilly; MabVax; Morphotek; Novartis
 
Mohammed M. Milhem
Honoraria - Amgen; EMD Serono
Consulting or Advisory Role - Amgen; EMD Serono
Travel, Accommodations, Expenses - Amgen; EMD Serono
 
Brian Andrew Van Tine
Consulting or Advisory Role - Advaxis; Caris Life Sciences; DFINE; EMD Serono; GlaxoSmithKline; Johnson & Johnson; Lilly/ImClone; Novartis; Threshold Pharmaceuticals
Speakers' Bureau - Caris Life Sciences; DFINE; GlaxoSmithKline
Research Funding - Morphotek; Polaris
 
AeRang Kim
No Relationships to Disclose
 
Brian Turpin
No Relationships to Disclose
 
Eva Dombi
No Relationships to Disclose
 
Nalini Jayaprakash
No Relationships to Disclose
 
Scott H. Okuno
Consulting or Advisory Role - Merck Serono
 
Lee J. Helman
No Relationships to Disclose
 
Ndidi Onwudiwe
Research Funding - Merck (Inst); Tesaro (Inst)
 
Seth M. Steinberg
No Relationships to Disclose
 
Denise K. Reinke
Research Funding - Bayer (Inst); Tesaro (Inst); Threshold Pharmaceuticals (Inst)
 
Karen Cichowski
No Relationships to Disclose
 
John Peter Perentesis
No Relationships to Disclose